Belgium· BE-AMP-SAM179033-00
Casodex 50 50 mg
A bicalutamide product containing bicalutamide, registered in Belgium by Laboratoires Juvise Pharmaceuticals. The same ATC class is registered in 18 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Bicalutamide is registered in 18 of 19 countries.
Countries holding a registration under ATC L02BB03 (bicalutamide), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 11 of them publish a price we can compare per daily dose
Bicalutamide · ATC L02BB03
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of bicalutamide costs, country by country.
Normalised to the WHO defined daily dose (50 mg), the median price runs from $1.21 in Italy to $2.29 in Switzerland — a ×1.9 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Bicalutamide · price per daily dose (50 mg)
USD · FX 28 Sept 2026
- CH Switzerland$2.29
- ES Spain$1.61
- FR France$1.42
- IT Italy$1.21
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Bicalutamide
- Manufacturer
- Laboratoires Juvise Pharmaceuticals
- Country
- Belgium (BE)
- ATC code
- L02BB03
- ATC class
- Bicalutamide
- Defined daily dose
- 50 mg, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
1 priced- be_apb1196997EUR 59.67
- be_apb0748541
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
477 interactions on record for bicalutamide.
Graded by severity as the source publishes them — 82 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Bicalutamide · interactions on record
477 records
- 82 severe
- 302 moderate
- 15 minor
- 78 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- LonafarnibA16AX20severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Bicalutamide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandBicalutamid ActavisActavis Group PTC ehf
- CzechiaBICALUPLEXTeva Pharmaceuticals CR, s.r.o., Praha
- SpainBICALUTAMIDA ACCORD 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFGAccord Healthcare S.L.U.
- ItalyBICALUTAMIDE AHCLACCORD HEALTHCARE SLU
- FranceBICALUTAMIDE ACCORD 50 mg, comprimé pelliculéACCORD HEALTHCARE FRANCE
- NetherlandsBicalutamide 50 PCH, filmomhulde tabletten 50 mgPharmachemie B.V.
- SwedenBicalustad 50 mg Filmdragerad tablettSTADA Arzneimittel AG
- IrelandBicalutamide 50 mg film-coated tabletsAccord Healthcare Ireland Ltd.
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Androbloc, Bicalutamid +pharma
- Bulgaria · Бикагратис, Бикалутамид Акорд
- Cyprus · Bicalutamide Rafarm, Bikalen
- Czechia · Bicaluplex, Bicalutanorm
- Germany · Bicadex, Bicalut
- Denmark · Bicalustad, Bicalutamid Bluefish
- Estonia · Bicalutamide Accord, Bicalutamide Teva
- Spain · Bicalutamida Accord, Bicalutamida Almus
- Finland · Bicalutamid Orion, Bicalutamide Accord
- France · Bicalutamide Accord, Bicalutamide Almus
- United Kingdom (Northern Ireland) · Bicalutamide, Bicalutamide Accord Healthcare
- Greece · Bicalut, Bicalutamide Rafarm
- Croatia · Bicaprox, Bikalis
- Hungary · Bicalutamide Pharmacenter, Bilutamid
- Ireland · Bicalutamide Accord, Bicalutamide Fair-Med
- Iceland · Bicalutamid Medical, Bicalutamide Accord
- Italy · Bicalutamide Accord, Bicalutamide Ahcl
- Lithuania · Bicalutamide Accord, Bicalutamide Teva
- Luxembourg · Bicalutamide Eg, Bicalutamide Teva
- Latvia · Bicalutamide Accord, Bicalutamide Teva
- Malta · Bicalutamide Pharmacare
- Netherlands · Bicalutamide Accord, Bicalutamide Aurobindo
- Norway · Bicalutamide Accord, Bicalutamide Bluefish
- Poland · Bicalutamide Accord, Binabic
- Portugal · Bicalutamida Accord, Bicalutamida Aurobindo
- Romania · Bicalutamida Accord, Bicalutamidă Accord
- Sweden · Bicalustad, Bicalutamid Sandoz
- Slovenia · Bikalutamid Accord, Bikalutamid Lek
- Slovakia · Bicagelan, Bicalutamid Teva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/eff1c246-66f0-4cd6-a496-01fce56a8665 GET /v1/drugs/eff1c246-66f0-4cd6-a496-01fce56a8665?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Casodex 50 50 mg",
"name_fr": "Casodex 50 50 mg",
"name_nl": "Casodex 50 50 mg",
"amp_code": "SAM179033-00",
"strengths": [
"50.0000",
"61.0000",
"7.5000"
],
"pack_count": 4,
"substances": [
"Bicalutamide",
"Lactose",
"Sodium Starch Glycolate"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Bicalutamide",
"authorisation_numbers": [
"BE179033"
]
}See everything about bicalutamide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.